Answers are grounded in this paper and cite their sources.
Reports the enhanced antifungal activity of epimerized yahazunol analogs in a fungal model, suggesting a new strategy for antifungal development.
We herein disclose that the epimerization of yahazunol can lead to an antifungal enhancement. Yahazunol-related drimane meroterpenoids and pseudonatural mimics were synthesized based on an improved synthesis of 9-epi-borono-sclareolide and the concomitant Suzuki coupling. Several 9-epi-drimane meroterpenoids presented antifungal activity. The new stereoisomer 9-epi-yahazunol (EC50 = 4.32 μM) and its analog S-T5 (EC50 = 2.8 μM) showed much better antifungal activity than yahazunol (EC50 >150 μM) against Rhizoctonia solani. Compound S-T5 possesses a promising in vivo efficacy against R. solani, with preventive efficacies of 87% and 71% at 100 and 50 μM, respectively. It not only induced wizened and wrinkled mycelia but also caused cell membrane damage or disruption in R. solani, as evidenced by a series of biochemical investigations. The biosafety assessment showed that S-T5 had no adverse effects on seed germination. Configuration inversion may be an alternative strategy for developing new potent antifungal mimics of drimane meroterpenoids.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: